Soluble OX40L favors tumor rejection in CT26 colon carcinoma model-Reference-Cited by-同舟云学术

Soluble OX40L favors tumor rejection in CT26 colon carcinoma model

Published:2016-08 Issue: Volume:84 Page:10-16
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Serebrovskaya Ekaterina O.,Yuzhakova Diana V.,Ryumina Alina P.,Druzhkova Irina N.,Sharonov George V.,Kotlobay Alexey A.,Zagaynova Elena V.,Lukyanov Sergey A.,Shirmanova Marina V.

Funder

Russian Academy of Sciences program

Russian Science Foundation

Russian President’s scholarship

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference38 articles.

1. Anti-tumour therapeutic efficacy of OX40L in murine tumour model;Ali;Vaccine,2004

2. Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances antitumor immunity of tumor-bearing hosts;Andarini;Cancer Res.,2004

3. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance;Bansal-Pakala;Nat. Med.,2001

4. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34;Baum;EMBO J.,1994

5. OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy;Bulliard;Immunol. Cell Biol.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-viral-mediated gene transfer of OX40 ligand for tumor immunotherapy;Frontiers in Immunology;2024-06-26

2. Oncolytic Efficacy of a Recombinant Oncolytic Virus Carrying OX40L inHepatocellular Carcinoma;PROG BIOCHEM BIOPHYS;2022

3. Advances in the Genetically Engineered KillerRed for Photodynamic Therapy Applications;International Journal of Molecular Sciences;2021-09-20

4. OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers;Translational Lung Cancer Research;2019-08

5. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation;Journal of Controlled Release;2018-06